Medprogresas, UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 116,989 |
| 20,966 |
| 20,144 |
| -20,144 |
| -3,610 |
| 26.29 |
| -17.22 |
| -25,649 |
| 339,630 |
| 258,146 |
| 55,835 |
| 0.31 |
| -13.24 |
| - |
| - |
| 26.29 |
| 30,752 |
| 2023 |
|---|
| 280,439 |
| 41,302 |
| 9,830 |
| 9,402 |
| 1,385 |
| 26.76 |
| 3.35 |
| 18,752 |
| 283,800 |
| 232,676 |
| 66,750 |
| 0.17 |
| 15.13 |
| 36.09 |
| 101,215 |
| 26.76 |
| 75,048 |
| 2024 |
|---|
| 258,020 |
| 35,491 |
| 13,309 |
| 12,704 |
| 1,747 |
| 21.21 |
| 4.92 |
| 31,456 |
| 213,596 |
| 185,016 |
| 56,708 |
| 0.17 |
| 6.79 |
| 41.33 |
| 106,649 |
| 21.21 |
| 54,728 |
| 2024 |
|---|
| 258,020 |
| 35,491 |
| 13,309 |
| 12,704 |
| 1,747 |
| 21.21 |
| 4.92 |
| 31,456 |
| 213,596 |
| 185,016 |
| 56,708 |
| 0.17 |
| 6.79 |
| 41.33 |
| 106,649 |
| 21.21 |
| 54,728 |
Turnover (€)
2024
Turnover (€)
258,020 €-8 % *
Sales per employee (€)
35,491 €-14 % *
Profit before tax (€)
13,309 €35 % *
Net Profit (€)
12,704 €35 % *
Profit per employee (€)
1,747 €26 % *
Total profitability (%)
21.21 %-20.74 % *
Net profitability (%)
4.92 %46.87 % *
Equity (€)
31,456 €68 % *
Amounts Payable And Liabilities (€)
213,596 €-25 % *
Non-current Assets (€)
185,016 €-20 % *
CurrentAssets (€)
56,708 €-15 % *
Working capital requirement
0.17 0.00 % *
Debt-to-equity ratio
6.79 -55.12 % *
EBITDA margin (%)
41.33 %14.52 % *
EBITDA (€)
106,649 €5 % *
EBIT margin (%)
21.21 %-20.74 % *
EBIT (€)
54,728 €-27 % *
